Gregory A Gaich

Affiliations

Goldfinch Bio, Inc., Cambridge, Massachusetts, USA.

Publications (1)

Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design.

Kidney international reports

Avec: Liron Walsh , John F Reilly , Caitlin Cornwall , Gregory A Gaich , Debbie S Gipson , Hiddo J L Heerspink , Leslie Johnson , Howard Trachtman , Katherine R Tuttle , Youssef M K Farag , Krishna Padmanabhan , Xin-Ru Pan-Zhou , James R Woodworth , Frank S Czerwiec

Réseau de co-auteurs

Liron Walsh 1 collaboration

John F Reilly 1 collaboration

Caitlin Cornwall 1 collaboration

Debbie S Gipson 1 collaboration

Hiddo J L Heerspink 1 collaboration

Leslie Johnson 1 collaboration

Howard Trachtman 1 collaboration

Katherine R Tuttle 1 collaboration

Youssef M K Farag 1 collaboration

Krishna Padmanabhan 1 collaboration

Xin-Ru Pan-Zhou 1 collaboration

James R Woodworth 1 collaboration

Frank S Czerwiec 1 collaboration